Glenmark launches a drug at almost half the price of those offered by rivals.

While Indian companies still control almost 80% of the market in the country, the strategy of launching specialised patented product is hel...

"Although hospital services are exempt, the outsourced services, aesthetics and outpatient pharmacies are subject to GST imposition."

The All India Organisation of Chemists and Druggists, which represents over 8 lakh chemists, has assured the government that supply of drug...

Stockists, worried they may suffer losses on account of a possible mismatch between tax payouts and tax refunds once GST kicks in, have sta...

AWACs found that anti-diabetic, cardiovascular and BP drugs have shown a significant increase in sales as compared to corresponding period ...

The combined market share of Sun Pharma (5.4% at present) and Ranbaxy (3.8%) will be 9.2%; much higher than that of the current No. 1 playe...

The proposed new entity would unseat Abbott from the top position, which holds current market share of 6.5%, according to research firm Aio...

The economic slowdown has hit the Rs 72,000- crore domestic pharma business, usually considered recession-proof.

The 72,000-crore domestic drug market could grow between 11% and 13% in 2013, according to projections by pharma market research firms.

“India is an under-diagnosed market, so the argument that less people are falling sick might not be true,” asserts Sujay Shetty, head of li...

The health ministry has suggested that the pricing of essential medicines be based on either the average price of the three cheapest brands...

Indian drugmakers posted 21% month-on-month growth in November sales, which was the highest in the past 14 months

The proposed national drug pricing policy will cost drugmakers close to 1,500 crore and stockists and traders collectively over 2,500 crore...